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Note from the EditorThirty years ago Dr. Mark Coventry, one of the pioneers of
arthroplasty and a mentor of mine at the Mayo Clinic, introduced
The Journal of Arthroplasty (JOA). It is now my great honor to intro-
duce Arthroplasty Today, an open-access, online journal sponsored
by the American Association of Hip and Knee Surgeons (AAHKS)
and published by Elsevier e global provider of information solu-
tions servingmore than 30million scientists, clinicians, information
professionals, students and educators worldwide. Arthroplasty
Today is a sister journal to the JOA.
The purpose of Arthroplasty Today is to present material to
practicing surgeons that will keep them abreast of developments
in the ﬁeld, prove useful in the care of patients with major joint
disability, and aid in understanding the scientiﬁc foundation of
this subspecialty area of orthopaedics. Our distinguished associate
editors and editorial board, as well as our peer reviewers, will
insure that this journal serves AAHKS members as well as the or-
thopaedic community as a whole. The international members of
the editorial board and international reviewers provide a world-
wide perspective.http://dx.doi.org/10.1016/j.artd.2014.12.001
2352-3441/Copyright © 2015 Published by Elsevier Inc. on behalf of American Associatio
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).While the focus of Arthroplasty Todaywill be the case report (see
editorial), we will consider varied content related to the clinical and
scientiﬁc foundations of joint replacement of the hip and knee.
Arthroplasty Today solicits manuscripts of the highest quality from
all areas of scientiﬁc endeavor that relate to joint replacement or
the treatment of its complications, including those dealingwith clin-
ical series andexperience, prostheticdesign, biomechanics, biomate-
rials, metallurgy, biologic response to arthroplasty materials in vivo
and in vitro that allow unique insight into any aspect of arthroplasty.
Our goal is to have an accelerated accreditation of Arthroplasty
Today so that all of our open access content is not only available
through Pub Med Central within a year, but also all manuscripts
are retroactively indexed by Pub Med.Brian J. McGrory, MD, MS
Editor-in-Chief
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